Filing Details

Accession Number:
0001585364-15-000010
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-02-24 16:26:47
Reporting Period:
2015-02-20
Filing Date:
2015-02-24
Accepted Time:
2015-02-24 16:26:47
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1585364 Perrigo Co Plc PRGO Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1398276 Thomas Farrington C/O Perrigo Company
515 Eastern Avenue
Allegan MI 49010
Senior Vp And Cio No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Disposition 2015-02-20 517 $151.18 321 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Ordinary Shares 2,098 Indirect By 401(k) Plan
Footnotes
  1. This transaction was effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on 12/1/2014. This 10b5-1 sales plan will expire on the close of business 12/1/2015.
  2. Price is a weighted average. Actual priced received ranged from $151.06 - $151.29. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each seperate price within the range.